Bafna Pharmaceuticals Ltd vs Decipher Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 139.65 as of 12 May 15:30 . The P/E Ratio of Bafna Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Decipher Labs Ltd changed from 24.1 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Decipher Labs Ltd changed from ₹ 33.78 crore on March 2021 to ₹ 10.62 crore on March 2025 . This represents a CAGR of -20.66% over 5 years The revenue of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Decipher Labs Ltd for the Dec '25 is ₹ 3.23 crore as compare to the Sep '25 revenue of ₹ 4.33 crore. This represent the decline of -25.4% The ebitda of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Decipher Labs Ltd for the Dec '25 is ₹ -0.41 crore as compare to the Sep '25 ebitda of ₹ 0.14 crore. This represent the decline of -392% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Decipher Labs Ltd changed from ₹ 0.95 crore to ₹ -0.54 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Decipher Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Decipher Labs Ltd

Decipher Labs Limited was initially incorporated as Combat Drugs Private Limited, as a Private Limited Company in September, 1986.
It was converted into a Public Limited Company and the name of the Company was changed to Combat Drugs Limited in June 1992.
Subsequently, the name of the Company was changed to Decipher Labs Limited dated 12 February, 2020. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry.
Since inception, the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations.

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Decipher Labs Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Decipher Labs Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 330 Cr while Market cap of Decipher Labs Ltd is 7 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Decipher Labs Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Decipher Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Decipher Labs Ltd?

As of May 12, 2026, the Bafna Pharmaceuticals Ltd stock price is INR ₹139.65. On the other hand, Decipher Labs Ltd stock price is INR ₹7.22.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Decipher Labs Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Decipher Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.